SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BDR who wrote (2619)3/3/1998 11:54:00 AM
From: David Pawlak  Read Replies (1) of 7041
 
Imagyn gets FDA clearance for ErecAid

(What do you guys make of this? I've never heard of these guys before)

NEWPORT BEACH, Calif., March 3 (Reuters) - Medical products maker Imagyn Medical
Technologies Inc said Tuesday it has received FDA 510 clearance to begin marketing its ErecAid
Vacuum Constriction Device (VCD) over-the-counter for treatment of erectile dysfunction in
men.

Imagyn chairman and chief executive Charles Laverty said in a news release, ''Clearance to
market this product over-the-counter provides Imagyn with an important new market
opportunity.''

Imagyn said VCDs are the least invasive approach for treating erectile dysfunction.

The devices have been endorsed by the American Urological Association as a treatment of first
choice for the condition, Imagyn said.

Chronic erectile dysfunction is estimated to affect more than 16 million men in the United States
with an additional 16 million men thought to experience intermittent erectile dysfunction, the
company said.

The company said in numerous studies ErecAid has achieved a 90 percent or greater success rate
among users and without any significant complications related to use.

''While large numbers of men suffer from erectile dysfunction, many are reluctant to seek
professional care,'' Laverty said. ''The ErecAid Classic will provide these men with a simple and
effective treatment.''

Imagyn said it will market the ErecAid Classic through its Urology Division utilizing its extensive
pharmacy network.

Imagyn designs, makes and markets disease-specific urological, gynecological and general
surgery medical products.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News